Chinese Journal of Cancer Research

Papers
(The median citation count of Chinese Journal of Cancer Research is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Gastric cancer surgery in South Korea: Past, present, and future75
Efficacy of ctDNA methylation combined with traditional detection modality to detect liver cancer among high-risk patients: A multicenter diagnostic trial62
Molecular features of gastroenteropancreatic neuroendocrine carcinoma: A comparative analysis with lung neuroendocrine carcinoma and digestive adenocarcinomas57
Focal ablation therapy presents promising results for selectively localized prostate cancer patients39
Efficacy and safety of low-dose cyclophosphamide combined with lenvatinib, pembrolizumab and TACE for unresectable hepatocellular carcinoma: A single-center, prospective, single-arm clinical trial39
Transforming cancer cells for long-term living with cancer: An inspiring new approach34
Heterogeneity of tumor-infiltrating myeloid cells in era of single-cell genomics33
Clinical and molecular significance of homologous recombination deficiency positive non-small cell lung cancer in Chinese population: An integrated genomic and transcriptional analysis33
Pathogenic germline variants in mismatch repair genes in patients with microsatellite instability-high gastric cancer33
National guidelines for diagnosis and treatment of thyroid cancer 2022 in China (English version)32
Tislelizumab in previously treated, locally advanced unresectable/metastatic microsatellite instability-high/mismatch repair-deficient solid tumors29
Microbiota and urinary tumor immunity: Mechanisms, therapeutic implications, and future perspectives29
Detection and classification of breast lesions using multiple information on contrast-enhanced mammography by a multiprocess deep-learning system: A multicenter study28
Mn-based cGAS-STING activation for tumor therapy26
Updates of CSCO guidelines for colorectal cancer version 202526
Multi-omics profile of exceptional long-term survivors of AJCC stage III triple-negative breast cancer25
Sequential neoadjuvant chemotherapy using pegylated liposomal doxorubicin and cyclophosphamide followed by taxanes with complete trastuzumab and pertuzumab treatment for HER2-positive breast cancer: A25
New roles of tumor-derived exosomes in tumor microenvironment19
Adjuvant tamoxifen switched to exemestane treatment in postmenopausal women with estrogen receptor-positive early breast cancer: A pragmatic, multicenter, and prospective clinical trial in China19
Prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer after curative surgery: Final results of a phase II trial18
Clinicopathological significance and immunotherapeutic outcome of claudin 18.2 expression in advanced gastric cancer: A retrospective study18
Hypoxic tumor microenvironment: Destroyer of natural killer cell function16
Optimal response population after neoadjuvant therapy for patients with locally advanced gastric cancer: A multicenter study16
Health economic evaluation on population-based Helicobacter pylori eradication and endoscopic screening for gastric cancer prevention16
Burden of liver cancer: From epidemiology to prevention15
Corrigendum to Comments on National guidelines for diagnosis and treatment of thyroid cancer 2022 in China (English version)15
A durable 4-1BB-based CD19 CAR-T cell for treatment of relapsed or refractory non-Hodgkin lymphoma15
Effect of microbiome group on immune checkpoint inhibitors in treatment of gastrointestinal tumors14
Postoperative chemoradiotherapy with capecitabine and oxaliplatin vs. capecitabine for pathological stage N2 rectal cancer14
Pan-cancer tumor-infiltrating T cells: A great hallmark in cancer immunology research14
Genomic characterization of peritoneal lavage cytology-positive gastric cancer14
Estimation of economic burden throughout course of cervical squamous intraepithelial lesion and cervical cancer in China: A nationwide multicenter cross-sectional study12
Long-term adherence to gastric cancer screening in South Korea: A 10-year follow-up study12
Research progress of minimally invasive surgery for gastric cancer12
Immune status and combined immunotherapy progression in Kirsten rat sarcoma viral oncogene homolog (KRAS) mutant tumors11
Adjuvant therapy for hormone receptor-positive breast cancer: Perspective from a survey on breast cancer physicians’ acceptance of practice-changing data10
Lung cancer burden and trends from 2000 to 2018 in China: Comparison between China and the United State10
SOX11 as a potential prognostic biomarker in hepatocellular carcinoma linked to immune infiltration and ferroptosis9
Predictors of pathologic complete response in patients with residual flat mucosal lesions after neoadjuvant chemoradiotherapy for locally advanced rectal cancer9
Comments on National guidelines for diagnosis and treatment of pancreatic cancer 2022 in China (English version)9
Development and validation of machine learning-based survival analysis to predict outcome in gastric cancer with adjuvant chemotherapy: A multicenter, longitudinal, cohort study9
Predictive value of co-expression patterns of immune checkpoint molecules for clinical outcomes of hematological malignancies9
Postoperative functional evaluation of gastrectomy for gastric cancer8
Variant rs8400 enhances ALKBH5 expression through disrupting miR-186 binding and promotes neuroblastoma progression8
Update of latest data for combined therapy for esophageal cancer using radiotherapy and immunotherapy: A focus on efficacy, safety, and biomarkers8
Clinicopathological and molecular features of HR+/HER2− breast cancer patients with distinct endocrine resistance patterns8
Discovery and validation of indole nitroolefins as novel covalent GPX4 inhibitors for inducing ferroptosis in urological cancers8
Advances, breakthroughs, and challenges in gastric cancer surgery8
Laparoscopic vs. open lower mediastinal lymphadenectomy for Siewert type II/III adenocarcinoma of esophagogastric junction: An exploratory, observational, prospective, IDEAL stage 2b cohort study (CLA7
Efficacy and safety of dacomitinib as first-line treatment for advanced non-small cell lung cancer patients with epidermal growth factor receptor 21L858R mutation: A multicenter, case-series study in 7
Molecular insights into immune evasion and therapeutic paradigms in pancreatic cancer7
Distal margin distance in radical resection of locally advanced rectal cancer after neoadjuvant therapy7
Allogeneic hematopoietic cell transplantation in vulnerable populations: Advances and perspectives7
Nonoperative management of gastrointestinal malignancies in era of neoadjuvant treatment6
Unveiling clinical significance and tumor immune landscape of CXCL12 in bladder cancer: Insights from multiple omics analysis6
Inducing immunogenic cell death in immuno-oncological therapies6
Subpopulation cooperation renders drug resistance of hepatobiliary tumor organoids6
Myeloid cells meet CD8+ T cell exhaustion in cancer: What, why and how6
Efficacy, safety, and multi-omics analysis of pembrolizumab combined with nab-paclitaxel and platinum as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carci6
Homoharringtonine combined with venetoclax and azacitidine: An effective and safe regimen for patients with refractory/relapsed acute myeloid leukemia6
Manufacturing CAR-NK against tumors: Who is the ideal supplier?6
Effectiveness and safety of combined nimotuzumab and S-1 chemotherapy with concurrent radiotherapy for locally advanced esophageal cancer in malnourished and elderly patients: A prospective phase II s6
Neoadjuvant chemotherapy with capecitabine combined with oxaliplatin for mid-low locally advanced rectal cancer with negative mesorectal fascia: Long-term outcomes of a prospective trial (PKUCH-R03 tr6
Prognostic implications of tumor-infiltrating lymphocytes in association with programmed cell death ligand 1 expression in remnant gastric cancer5
Immune cell metabolism in cancer drug resistance: Advances in target discovery and clinical translation5
Prognostic value of post-transplantation measurable residual disease in patients with myelodysplastic syndrome: A prospective cohort study5
Establishment of an optimized CTC detection model consisting of EpCAM, MUC1 and WT1 in epithelial ovarian cancer and its correlation with clinical characteristics5
Genomic landscape of T-cell lymphoblastic lymphoma5
CSCO guidelines for colorectal cancer version 2023: Updates and insights5
National validation of laparoscopic approach for locally advanced gastric cancer: Comparison of a randomized controlled trial and real-world practice results5
A multicenter study on the efficacy of dual-target neoadjuvant therapy for HER2-positive breast cancer and a consistent analysis of the efficacy evaluation of neoadjuvant therapy by Miller-Payne and R5
Integrated analysis of single-cell and bulk transcriptomes uncovers clinically relevant molecular subtypes in human prostate cancer5
Reprogramming of fatty acid metabolism in thyroid cancer: Potential targets and mechanisms5
Coupling radiomics analysis of CT image with diversification of tumor ecosystem: A new insight to overall survival in stage I−III colorectal cancer5
National guidelines for diagnosis and treatment of breast cancer 2022 in China (English version)4
Microbiota in colorectal cancer related to liver metastasis4
Management guidelines for preventing exposure to antineoplastics4
Tumor-derived DEFB1 induces immune tolerance by inhibiting maturation of dendritic cell and impairing CD8+ T cell function in esophageal squamous cell carcinoma4
Epidemiology of pancreatic cancer: New version, new vision4
New insights into mechanisms and interventions of locoregional therapies for hepatocellular carcinoma4
CT-based radiomics-deep learning model predicts occult lymph node metastasis in early-stage lung adenocarcinoma patients: A multicenter study4
A novel multimodal prediction model based on DNA methylation biomarkers and low-dose computed tomography images for identifying early-stage lung cancer4
Corrigendum to Efficacy and safety of low-dose cyclophosphamide combined with lenvatinib, pembrolizumab and TACE for unresectable hepatocellular carcinoma: A single-center, prospective, single-arm cli4
Pyrotinib is effective in both trastuzumab-sensitive and primary resistant HER2-positive breast tumors4
MRD-directed and risk-adapted individualized stratified treatment of AML4
Advances in surgical techniques for gastric cancer: Indocyanine green and near-infrared fluorescence imaging. Is it ready for prime time?4
Enhancing diagnostic accuracy: Role of stomach-specific serum biomarkers in real-world risk-based sequential screening for malignant gastric lesions4
Circulating tumor DNA and its role in detection, prognosis and therapeutics of hepatocellular carcinoma3
Targeted activation of junctional adhesion molecule-like protein+ CD8+ T cells enhances immunotherapy in hepatocellular carcinoma3
Artificial intelligence efficiently predicts gastric lesions, Helicobacter pylori infection and lymph node metastasis upon endoscopic images3
Nucleotide excision repair gene polymorphisms and hepatoblastoma susceptibility in Eastern Chinese children: A five-center case-control study3
A multi-center, open-label, randomized, parallel-controlled phase II study comparing pharmacokinetic, pharmacodynamics and safety of ripertamab (SCT400) to rituximab (MabThera� in patients with CD20-p3
IMpower210: A phase III study of second-line atezolizumab vs. docetaxel in East Asian patients with non-small cell lung cancer3
Challenge and future of cancer screening in China: Insights from esophageal cancer screening practice3
A comparative transcriptomic analysis at single-cell resolution reveals acral melanoma features distinct from cutaneous melanoma3
Clinical outcomes of atezolizumab in combination with etoposide/platinum for treatment of extensive-stage small cell lung cancer: A real-world, multicenter, retrospective, controlled study in China3
Context-dependent roles of 5-HT and its receptors in tumor growth and wound healing: Mechanisms and therapeutic implications3
National guidelines for diagnosis and treatment of melanoma 2022 in China (English version)3
A phase I study of Hemay022, an irreversible dual EGFR/HER2 tyrosine kinase inhibitor in Chinese patients with HER2-positive advanced breast cancer3
When immunotherapy meets liver transplantation for hepatocellular carcinoma: A bumpy but promising road3
Venetoclax and azacitidine compared with intensive chemotherapy for adverse-risk acute myeloid leukemia patients receiving allogeneic hematopoietic stem cell transplantation in first complete remissio3
Aqueous-soluble components of sporoderm-removed Ganoderma lucidum spore powder promote ferroptosis in oral squamous cell carcinoma3
Exploring ideal operative time for best outcomes in gastric cancer surgery: A multi-institutional study based on KLASS-07 database3
Efficacy analysis of Cheng’s GIRAFFE reconstruction after proximal gastrectomy for adenocarcinoma of esophagogastric junction3
Association of lifestyle factors with breast cancer incidence: An overview of systematic reviews3
Adaptive neoadjuvant endocrine therapy screens out prime population of ribociclib intensive adjuvant therapy3
Global, regional, and national burden of colorectal cancer, 1990−2021: An analysis from global burden of disease study 20213
0.61200308799744